by Admin | Apr 13, 2021 | News & Opinions
Wellington, FL — On June 14-18, 2021, the Regenerative Medicine Foundation (RMF) and Wake Forest Institute for Regenerative Medicine (WFIRM) will broadcast the combined event showcasing global experts, luminaries and visionaries from government, science, medicine,...
by Admin | Apr 8, 2021 | News & Opinions
Diabetes Research Institute Investigators Will Lead the First Site Activated for the Vertex Study MIAMI, FL – April 6, 2021 – Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals...
by Admin | Apr 7, 2021 | News & Opinions
Durham, NC – According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the past. The trial involved injecting diabetes patients...
by Admin | Mar 26, 2021 | News & Opinions
Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent,...
by Admin | Mar 22, 2021 | News & Opinions
Durham, NC – The standard of treatment for bone tumors is often two-fold: surgery to remove the cancerous section followed by raadiation therapy to ensure all the cancerous cells have been killed off. This is an effective way to defeat bone tumors; however, it often...
by Admin | Mar 16, 2021 | News & Opinions
MIAMI, March 11, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced...
